Novast Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has seventy-four approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Drugs and US Patents for Novast Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208783-001 | Jun 14, 2019 | AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Novast Labs | NADOLOL | nadolol | TABLET;ORAL | 210786-002 | Jun 1, 2018 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Novast Labs | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 208357-002 | Jun 6, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.